NOT-HL-18-623: NHLBI Announces Participation in PA-17-446 "Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R21)"

NHLBI Announces Participation in PA-17-446 "Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R21)"

Notice Number: NOT-HL-18-623

Key Dates
Release Date: May 15, 2018

Related Announcements
NOT-HL-18-621
NOT-HL-18-622
PA-17-444
PA-17-445
PA-17-446

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Heart, Lung, and Blood Institute (NHLBI) is participating in PA-17-446 "Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21)" effective immediately.

The following sections of PA-17-446 have been updated to reflect the participation of NHLBI in this Funding Opportunity Announcement (FOA):

Part 1. Overview Information

Components of Participating Organizations
National Human Genome Research Institute (NHGRI)
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute on Aging (NIA)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute on Minority Health and Health Disparities (NIMHD)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.172; 93.399; 93.307; 93.173; 93.853; 93.866; 93.113; 93.865; 93.233; 93.837; 93.838; 93.839; 93.840

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

Areas of Research Interest
The NHLBI is interested in applications that address the ethical, legal, and social issues arising from genomic research on heart, lung, blood, and sleep diseases and disorders. In addition, the NHLBI is especially interested in applications that address ELSI topics relevant to its Strategic Vision. Guidance about NHLBI's specific ELSI research priorities is forthcoming and will be posted on the NHGRI's ELSI Research Domains website. For additional scientific program information and for pre-application guidance, potential applicants are encouraged to contact the NHLBI Scientific/Research Contact listed in Section VII. Agency Contacts.

Section VII. Agency Contacts

Scientific/Research Contact(s)
Mollie Minear, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0448
Email: [email protected]

Financial/Grants Management Contact(s)

Debbie Chen
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-8023
Email: [email protected]

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Mollie Minear, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0448
Email: [email protected]